US 2011/0086102 A1Published application

Delayed release compositions

AssigneeTeva Pharmaceutical Industries Ltd.

InventorsDavid Isaac SILVER, Julia Hrakovsky, Roey Solomonovich, Dafna Arieli

Life of this patent

Estimating the term…

Abstract

The present invention provides delayed release pharmaceutical compositions comprising an active pharmaceutical ingredient, e.g. mycophenolate sodium, and an enteric polymer, and methods for preparing the same. Preferably, the pharmaceutical compositions do not contain a coating.

Claims40

Dependent claims

A delayed release pharmaceutical composition comprising an active pharmaceutical ingredient selected from mycophenolic acid, a pharmaceutically acceptable salt thereof or combinations thereof, wherein said delayed release is matrix controlled.

Dependencies are inferred from the claim text.

Facts

Application: 12/578,434Filed 13 Oct 2009
Published: 14 Apr 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/343
Having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide: condensed with a carbocyclic ring, e.g. coumaran,…
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/204
Obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers:…
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results